Related Experiment Video
Updated: Jan 22, 2026

Examining BCL-2 Family Function with Large Unilamellar Vesicles
Published on: October 5, 2012
Long non-coding RNA SNHG1 protects human AC16 cardiomyocytes from doxorubicin toxicity by regulating miR-195/Bcl-2
Sisi Chen1,2,3, Jichun Wang4,2,3, Yanli Zhou4,2,3
1Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China chensisi6617@163.com.
Abstract:
Doxorubicin (DOX) is a highly effective anti-tumor drug, but its cardiotoxicity largely restricts its clinical application. The present study was designed to explore whether in vitro DOX toxicity in AC16 cardiomyocytes can be regulated by long non-coding RNA (lncRNA) small nucleolar RNA host gene 1 (SNHG1) and to elucidate the underlying mechanisms. We found that DOX treatment led to severe damage in AC16 cells through decreasing cell viability and increasing cell apoptosis. DOX treatment also reduced the expression of SNHG1 in AC16 cells, and overexpression of SNHG1 alleviated the increased apoptosis in DOX-treated AC16 cells. Moreover, we found that SNHG1 could counteract the inhibitory effect of miR-195 on Bcl-2, and miR-195 restoration blocked the beneficial effect of SNHG1 against DOX toxicity in AC16 cells. In short, the present study provided convincing evidence that SNHG1 protects human AC16 cardiomyocytes from DOX toxicity partly by regulating miR-195/Bcl-2 axis.
Insights
Long non-coding RNA SNHG1 protects heart cells from Doxorubicin toxicity by regulating the miR-195/Bcl-2 pathway. This finding offers potential therapeutic strategies for mitigating chemotherapy-induced heart damage.
Area of Science:
- Cardiology
- Molecular Biology
- Oncology
Background:
- Doxorubicin (DOX) is a potent anti-cancer drug.
- DOX-induced cardiotoxicity limits its clinical use.
- The role of long non-coding RNAs (lncRNAs) in DOX cardiotoxicity is under investigation.
Purpose of the Study:
- To investigate the regulatory role of lncRNA SNHG1 in Doxorubicin toxicity in AC16 cardiomyocytes.
- To elucidate the molecular mechanisms underlying SNHG1's effect on DOX-induced cardiotoxicity.
Main Methods:
- AC16 cardiomyocytes were treated with Doxorubicin (DOX).
- Expression levels of SNHG1 and miR-195 were analyzed.
- Cell viability and apoptosis were assessed.
- The interaction between SNHG1, miR-195, and Bcl-2 was investigated.
Main Results:
- DOX treatment decreased AC16 cell viability and increased apoptosis.
- DOX reduced SNHG1 expression in AC16 cells.
- Overexpression of SNHG1 attenuated DOX-induced apoptosis.
- SNHG1 counteracted miR-195's inhibition of Bcl-2; miR-195 restoration abolished SNHG1's protective effect.
Conclusions:
- SNHG1 protects human AC16 cardiomyocytes against Doxorubicin toxicity.
- This protection is partly mediated by the regulation of the miR-195/Bcl-2 axis.
- SNHG1 represents a potential therapeutic target for managing DOX cardiotoxicity.
Related Concept Videos
lncRNA - Long Non-coding RNAs
Epigenetic Regulation
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Regulated mRNA Transport
Hypothalamic-Pituitary Axis
Ribosomal RNA Synthesis
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...

